Figure 3.
Site-specific effects of CYP2D6 metabolizer status on clinical outcomes for subjects meeting inclusion criterion 1 (outcome = breast cancer–free interval (BCFI)).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.